WallStSmart

Blend Labs Inc (BLND)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 109% more annual revenue ($258.90M vs $123.58M). BLND leads profitability with a -5.5% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

BLND

Avoid

32

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 6.0Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BLNDUndervalued (+21.3%)

Margin of Safety

+21.3%

Fair Value

$2.25

Current Price

$1.46

$0.79 discount

UndervaluedFair: $2.25Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BLND0 strengths · Avg: 0/10

No standout strengths identified

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

BLND4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$375.39M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-0.8%2/10

ROE of -0.8% — below average capital efficiency

Free Cash FlowQuality
$-21,0002/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : BLND

BLND has a balanced fundamental profile.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : BLND

The primary concerns for BLND are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

BLND profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 32/100) and 43.0% revenue growth. BLND offers better value entry with a 21.3% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Blend Labs Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Blend Labs Inc. (BLND) is an innovative fintech leader that is revolutionizing the lending landscape with its state-of-the-art digital platform aimed at enhancing operational efficiency and customer experience for financial institutions. Catering to a wide array of clients—including banks, credit unions, and mortgage lenders—Blend offers tailored solutions that leverage data-driven insights to optimize the loan origination process. The company is dedicated to empowering its partners to deliver personalized financial products, helping them stay competitive in an increasingly digital marketplace. With a strategic focus on expanding its market footprint through collaborations and the continual integration of advanced technologies, Blend is well-positioned for sustained growth in the dynamic fintech sector.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?